Ambulatory Surgery Centers (ASC) Market Outlook: Sustained Growth Amid Healthcare Shifts

The Ambulatory Surgery Center (ASC) market is poised for steady and reliable expansion over the next five years

Healthcare M&A Is Shrinking. Who’s Still Buying?

R&D Spending Surges as Sleep Tech Heats Up

Pharma R&D Spending Rises, Rouge Tx Advances, and Sleep Tech Scales

The New R&D Playbook in the AI Era

Life sciences spent decades optimizing the R&D pipeline. AI is beginning to change the pipeline itself.

A Hepatitis B Breakthrough, Merck’s $1B Bet

FDA approval for potential Hepatitis B cure, Biomedical Engineering scaling fast, and Merck's $1B acquisition

The Cyber Problem Holding Back AI

AI’s Cybersecurity Problem, Estuary Bio, and the Oncology Pharma Power Map

AI in Hospitals Meets the Agentic Economy: The Cybersecurity Reckoning

AI in Hospitals and the Cybersecurity Implications of the Agentic Economy

FDA Shifts Rare Disease Rules as Biotech M&A Heats Up

Rare Disease Biotech Could Get a New Risk Profile

$42B → $82B: healthcare staffing doubles

Plus: why 59% of health systems are moving past cost-cutting.

Healthcare’s Workforce Imperative: The Investment Case for the Next Era of Staffing

Tariffs Changed the MedTech Playbook

Pharma’s $130B M&A Comeback, China’s Innovation Rise, Healthcare’s Third-Party Risk

Biopharma dealmaking is accelerating as drug innovation goes global—and China closes the gap with the U.S.